Pandemic Expert Warns Again Black Market Covid Drugs

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2023-01-21 HKT 11:49

Share this story

facebook

  • Pandemic expert warns again black market Covid drugs

Government pandemic advisor David Hui on Saturday said members of the public should not to buy oral Covid drugs on the black market, as a prescription was needed to ensure safety.

"It is not advisable to go to the black market to purchase unregistered drugs because you don't know whether there will be drug interaction," he said, citing scenarios when doctors have to prescribe specific Covid drugs to patients taking other medicine.

Speaking after attending a radio programme, the Chinese University respiratory medicine professor said for example the registered antiviral Paxlovid, which is made by the US drug company Pfizer and is used here legally to treat many Covid patients, was not suitable for a person taking anticoagulants or antiarrhythmics.

So far this month, Customs have made two large seizures of unregistered oral Covid drugs with officers on Friday announcing 2,100 boxes had been confiscated at the airport. It followed a bust last week at the airport and at a Tin Shui Wai flat.

With regard to public hygiene, Professor Hui said Hong Kong should follow the example of some other Asian countries and mandate mask wearing in certain situations, even if the general mask wearing mandate were to be cancelled following the winter flu season.

"There are some scenarios in which we need to continue universal masking - including travelling by public transport, going to healthcare facilities like hospitals and clinics, and in the nursing home and disabled home settings. Because these are the high-risk areas," Hui said, citing similar measures in Singapore and South Korea.

His comment comes two days after health authorities announced that from January 30 people with Covid will no longer have to isolate or report their infections to health authorities.

RECENT NEWS

Revolut Considers China Expansion Amid UK Regulatory Hurdles

UK fintech giant Revolut is exploring a potential move into China, setting the stage for competition with domestic heav... Read more

ZA Global Backs RD Technologies With US$40M To Boost HKs Stablecoin Ecosystem

ZA Global has led a US$40 million Series A2 funding round for HK fintech firm, RD Technologies (RD), marking a signific... Read more

WeLab Hit Profitability And Now Wants 500 Million Customers Across Asia

From its humble beginnings as an online lender to its rise as one of Asia’s most ambitious fintechs, WeLab Group (WeL... Read more

HKMA Finalises Guidelines For Stablecoin Issuer Regulatory Regime

The Hong Kong Monetary Authority (HKMA) has published several documents in preparation for the implementation of the re... Read more

Cybercrime Is Surging Across APAC Yet Defences Remain Fragmented

APAC saw a sharp rise in human-led attacks in 2024, with attack rates growing over 60% year-on-year and increasing 37% ... Read more

Hong Kong Advances Trade Digitalisation With MLETR Adoption

Digitalisation is reshaping the global economy, and businesses must adapt to capitalise on emerging opportunities. In t... Read more